Transcriptional activation of cathepsin D gene expression by 17β-estradiol: Mechanism of aryl hydrocarbon receptor-mediated inhibition

Molecular and Cellular Endocrinology

Volumn 172, Issue 1-2, 2001, Pages 91-103

  Wang, Fan ^a   Samudio, Ismael ^a   Safe, Stephen ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Ah receptor; Cathepsin D; ER; Inhibitory crosstalk

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CATHEPSIN D; ESTRADIOL; ESTROGEN RECEPTOR; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1;

ADENOVIRUS; ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA FOOTPRINTING; DNA RESPONSIVE ELEMENT; DRUG MECHANISM; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSACTIVATION;

BREAST NEOPLASMS; CATHEPSIN D; DOWN-REGULATION; ESTRADIOL; FEMALE; HUMANS; PROMOTER REGIONS (GENETICS); RECEPTORS, ARYL HYDROCARBON; RESPONSE ELEMENTS; TETRACHLORODIBENZODIOXIN; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

EID: 0035857478     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(00)00379-8     Document Type: Article

References (68)

1. Constitutive function of the basic helix-loop-helix/PAS factor Arnt. Regulation of target promoters via the E box motif
2. Characterization of the proximal estrogen-responsive element of human cathepsin D gene
3. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
4. Molecular basis of agonism and antagonism in the oestrogen receptor
5. Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription
6. Cloning and expression of a novel dominant-negative-acting estrogen response element-binding protein in the heterogeneous nuclear ribonucleoprotein family
7. Mechanisms of action of steroid hormones
8. Antiestrogenic effects of all-trans -retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms
9. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma
10. Control of human breast cancer by estrogen, growth factors, and oncogenes
11. Transcriptional activation of c-fos protooncogene by 17β-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition
12. The vascular protective effects of estrogen
13. Orphan receptor hepatocyte nuclear factor-4 antagonizes estrogen receptor α-mediated induction of human coagulation factor XII gene
14. Correlation of in vitro and in vivo growth suppression of MCF-7 human breast cancer by 2,3,7,8-tetrachlorodibenzo-p-dioxin
15. Identification of a motif within the 5′-regulatory region on pS2 which is responsible for Ap1 binding and TCDD-mediated suppression
16. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription
17. Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin
18. Nuclear receptor coactivators corepressors
19. Estrogen action in target cells: selective requirements for activation of different hormone response elements
20. The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERα and ERβ
21. Molecular mechanisms of antiestrogen action in breast cancer
22. Antiestrogens: mechanisms and actions in target cells
23. Tripartite steroid hormone receptor pharmacology-interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones
24. Chromatin structure mapping in vivo using methyltransferases
25. Direct study of DNA-protein interactions in repressed and active chromatin in living cells
26. The aryl hydrocarbon receptor interacts with estrogen receptor α and orphan receptors COUP-TFI and ERRα1
27. Chicken ovalbumin upstream promoter-transcription factor interacts with estrogen receptor, binds to estrogen response elements and half-sites, and inhibits estrogen-induced gene expression
28. Results of a 2-year chronic toxicity and oncogenicity study of 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) in rats
29. Estrogens
30. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells
31. Cloning of a novel receptor expressed in rat prostate and ovary
32. A retinoic acid response element that overlaps an estrogen response element mediates multihormonal sensitivity in transcriptional activation of the lactoferrin gene
33. Development of antiestrogens and their use in breast cancer: eighth Cain Memorial Award Lecture
34. Mechanisms of growth control in normal and malignant breast epithelium
35. Retinoic acid receptor β mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells
36. COUP-TF acts as a competitive repressor for estrogen receptor-mediated activation of the mouse lactoferrin gene
37. Basic guide to the mechanisms of antiestrogen action
38. The nuclear receptor superfamily: the second decade
39. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens
40. Mechanism of action of α-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells
41. Benzo[a]pyrene-resistant MCF-7 human breast cancer cells. A unique aryl hydrocarbon-nonresponsive clone
42. β: identification and characterization of a novel human estrogen receptor
43. Endocrine therapy for advanced breast cancer-a review
44. Peptide antagonists of the human estrogen receptor
45. Estrogen receptor (ER) modulators each induce distinct conformational changes in ERα and ERβ
46. Estrogenic and antiestrogenic compounds
47. Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression
48. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds
49. Inhibition of estrogen-responsive gene activation by the retinoid X receptor β: evidence for multiple inhibitory pathways
50. c-Myc is a major mediator of the synergistic growth inhibitory effects of retinoic acid and interferon in breast cancer cells
51. Protein-DNA interactions at a dioxin-responsive enhancer-mutational analysis of the DNA-binding site for the liganded Ah receptor
52. Possible function of Ah receptor nuclear translocator (Arnt) homodimer in transcriptional regulation
53. DNA binding specificities and pairing rules of the Ah receptor, ARNT, and SIM proteins
54. Specificity of DNA binding of the c-Myc/Max and ARNT/ARNT dimers at the CACGTG recognition site
55. Inhibition of the transcription of CYP1A1 gene by the upstream stimulatory factor 1 in rabbits
56. Upstream stimulatory factor 1 (USF1) suppresses induction of CYP1A1 mRNA by 3-methylcholanthrene (MC) in HepG2 cells
57. Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats
58. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors
59. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
60. Skeletal effects of estrogen
61. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions
62. Functional and physical interactions between the estrogen receptor-Sp1 and the nuclear aryl hydrocarbon receptor complexes
63. Identification of a functional imperfect estrogen responsive element in the 5′-promoter region of the human cathepsin D gene
64. Regulation of constitutive gene expression through interactions of Sp1 protein with the nuclear aryl hydrocarbon receptor complex
65. 1 phase identified in synchronized T-47D breast cancer cells
66. Upstream stimulatory factors mediate estrogen receptor activation of the cathepsin D promoter
67. DNA sequence determinants for binding of transformed Ah- receptor to a dioxin-responsive enhancer
68. Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17β-estradiol-induced pS2 expression